Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
Details for Australian Patent Application No. 2001216040 (hide)
International Classifications
Event Publications
15 June 2006 Application Accepted
Published as AU-B-2001216040
12 October 2006 Standard Patent Sealed
12 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2001216071-5HT2 agonists for controlling IOP and treating glaucoma
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser